KNB Kanabo Group PLC

Kanabo Launches eCommerce Platform to Help Improve Wellbeing of Millions of People

Kanabo, the UK medicinal cannabis company focusing on the development and distribution of cannabis-derived products for medical patients, is launching its eCommerce platform for wellness CBD consumers.

The Kanabo.store will cater to the UK market initially and then roll out across Europe, giving CBD consumers access to Kanabo’s three proprietary CBD formula pods that work with Kanabo’s unique VapePod, the first of its kind medical grade vaporiser that provides easy-to-use metered dosing.

Relax helps you quiet your mind and find your inner tranquility with a calming blend of CBD and carefully chosen terpenes, Reload resets your clarity and focus with a stimulating blend of CBD and reinvigorating terpenes while Repair helps release your tension, regain your balance and get back on track with a powerful blend of CBD, CBG and carefully selected terpenes.

The world renowned R&D team at Kanabo, the first medicinal cannabis company to IPO on the London Stock Exchange, has made the VapePod a real game changer as it gives a metered dose of 1mg on every inhalation, so consumers know the exact amount consumed – and exactly what it is they are inhaling.

Thanks to the rapid onset of cannabinoids delivered to the body by simply inhaling, the VapePod offers the shortest delivery time with noticeable effects via the pulmonary tract. The device cuts out as soon as it reads that 1mg of CBD has been inhaled. The VapePod’s bioavailability is higher compared to other delivery methods as the body does not flush out a lot of the product as it can do with capsules or tinctures.

The CBD Pods are manufactured in the UK and the portable and easy to use VapePod is discreet for social or work settings. Each CBD Pod contains 300 doses per unit and the hemp from which our broad spectrum CBD is made contains minor cannabinoids and hemp terpenes that are naturally sourced and are manufactured at an EU-GMP facility, meeting the highest production standards worldwide. Kanabo’s CBD formulas boast a huge 80% cannabinoids (360 mg of CBD) and are made with only pure hemp ingredients; 100% vegan and without any commonly added diluents such as harmful PG, VG, MCT or PEG oils.

Avihu Tamir, founder and CEO of Kanabo, said: “Our VapePod is a game-changer for CBD consumers who aim to improve their health and quality of life.

“No other CBD delivery system currently on the market offers the same precise, metered dosing solution that the VapePod consistently provides. We use the highest quality hemp-derived natural ingredients which makes the VapePod the most effective CBD delivery system in the world.”

The VapePod can also be used for medicinal cannabis as it allows physicians to now confidently prescribe accurate and precise micro doses of cannabis and collect accurate patient data.

Link to site:

For more information, please email .

EN
23/03/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Kanabo Group PLC

 PRESS RELEASE

Kanabo Launches eCommerce Platform to Help Improve Wellbeing of Millio...

LONDON--(BUSINESS WIRE)-- Kanabo, the UK medicinal cannabis company focusing on the development and distribution of cannabis-derived products for medical patients, is launching its eCommerce platform for wellness CBD consumers. The Kanabo.store will cater to the UK market initially and then roll out across Europe, giving CBD consumers access to Kanabo’s three proprietary CBD formula pods that work with Kanabo’s unique VapePod, the first of its kind medical grade vaporiser that provides easy-to-use metered dosing. Relax helps you quiet your mind and find your inner tranquility with a calming ...

 PRESS RELEASE

Kanabo Upgrades CBD Manufacturing to EU GMP, Partners with Pure Origin...

LONDON--(BUSINESS WIRE)-- London, UK based medical cannabis R&D company, Kanabo Group Plc, has partnered with Pure Origin Ltd., a leader in best practices for EU GMP manufacturing. Good Manufacturing Practices (GMPs) are systems created and authorised by the government to regulate production, verification and validation of drugs, food and/or medical devices, ensuring that finished products are effective and safe for market distribution. Under the agreement Pure Origin will manufacture, package and supply Kanabo’s CBD wellness product line from their EU GMP manufacturing facility in Wales. The...

 PRESS RELEASE

Kanabo Strengthens Operations Team, Welcoming Michal Ben Moshe as Gene...

LONDON--(BUSINESS WIRE)-- Kanabo Group Plc is thrilled to announce the new appointment of Michal Ben Moshe as General Manager. Michal will be tasked with operational execution of the Company’s business plan, overseeing company goals and curating an agile team to support and enable its growth. Michal will report directly to Kanabo’s CEO, Avihu Tamir. Michal was chosen specifically for the 20 years of leadership experience that she brings having worked as the Senior Director of Finance & Commercial Affairs at S.L.E Ltd., one of the leading providers of logistic and operations in the healthcare ...

 PRESS RELEASE

Kanabo Group Announces Agreement with PharmaCann Polska for a First-of...

LONDON--(BUSINESS WIRE)-- Kanabo Group Plc, has announced its second key agreement following its hugely successful IPO two weeks ago, with PharmaCann Polska. Under the agreement, PharmaCann and Kanabo will establish a customized production line for Kanabo’s VapePods cartridges. The initial production capability will be approximately 36,000 cartridges a month with the ability to increase production later in the year. The cartridges are an essential part of Kanabo’s VapePod® platform, a medically certified inhalation device that works with patented, precision-targeted formulas. The vaporiser de...

2 directors sold

Two Directors at Spinnaker Opportunities sold 3,200,000 shares at 5.00p. The significance rating of the trade was 73/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch